Photo by nci from unsplash
The development of newer strategies to improve outcomes for older patients with secondary acute myeloid leukemia (s‐AML) is a critical unmet need. Establishing baseline metrics for evaluating newer approaches is… Click to show full abstract
The development of newer strategies to improve outcomes for older patients with secondary acute myeloid leukemia (s‐AML) is a critical unmet need. Establishing baseline metrics for evaluating newer approaches is important.
Keywords:
patients secondary;
outcomes older;
myeloid leukemia;
secondary acute;
acute myeloid;
older patients
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!